# Ginkgo Bioworks Holdings, Inc.: Form 8-K, filed Jun 12, 2026

- Company: [Ginkgo Bioworks Holdings, Inc.](/companies/dna.md) (CIK 1830214)
- Form: 8-K
- Filed: 2026-06-12
- Accepted by EDGAR: Jun 12, 2026, 17:00 ET
- Period: 2026-06-11
- Accession: 0001628280-26-042932
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/dna-20260611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1830214/000162828026042932/dna-20260611.htm

Filed Jun 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-042932. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.